Home » News » India » ‘Sputnik V Production in India to be Ramped Up to 850 Mn Doses a Year, Single-Shot Jab Soon’: Russian Envoy
2-MIN READ

‘Sputnik V Production in India to be Ramped Up to 850 Mn Doses a Year, Single-Shot Jab Soon’: Russian Envoy

News18.com

Last Updated: May 16, 2021, 10:23 IST

Representative image of Sputnik V Vaccine. Reuters

Representative image of Sputnik V Vaccine. Reuters

Russian Ambassador to India N. Kudashev says Sputnik V is a ‘Russian-Indian vaccine’, and its efficacy is ‘well-known in the world’.

Production of Sputnik V in India is expected to be gradually ramped up to produce 850 million doses per year, said Russian Ambassador to India N. Kudashev on Sunday.

The envoy said Sputnik V is a “Russian-Indian vaccine”, adding that they expect its production in India to be gradually increased, news agency ANI reported.

He also added that there are plans to introduce a single-dose vaccine soon in India, called ‘Sputnik Lite’.

Emphasising on the effectiveness of the vaccine, Kudashev said its efficacy is “well-known in the world”.

“In Russia, it’s being successfully used to vaccinate citizens starting since 2nd half of 2020. Russian specialists declared it’s also effective against new Covid-19 strains,” he added.

Meanwhile, the second batch of Sputnik V arrived in Hyderabad on Sunday.

The first consignment had landed in India on May 1 after regulatory clearance from the Central Drugs Laboratory.

The vaccine is likely to be available in the market from next week, the Centre had said on Thursday amid a severe vaccine shortage.

On Friday, Hyderabad-based Dr Reddy’s Laboratories, the local partner for the vaccine, had soft-launched Sputnik V in India with imported doses, which would cost Rs 995 per shot.

A top executive at Dr Reddy’s told CNN-News18 Saturday that India will receive a total of 250 million doses of Sputnik V over the next 8-10 months and its production here is expected to begin from July.

Deepak Sapra, CEO, API & Services at Dr Reddy’s, also said that once the India-manufactured product is available, the pricing for the vaccine will be different. Sapra also took the first shot of the vaccine in Hyderabad on Friday.

At 91.6 per cent, Sputnik V has a higher efficacy as compared to the two Covid-19 vaccines that are currently being administered in India: Oxford-AstraZeneca’s Covishield, manufactured by the Serum Institute of India, and Bharat Biotech’s Covaxin.

Read all the Latest News, Breaking News and Coronavirus News here. Follow us on Facebook, Twitter and Telegram.

first published:May 16, 2021, 10:23 IST
last updated:May 16, 2021, 10:23 IST